KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
185 hedge funds and large institutions have $2.24B invested in Chinook Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 59 increasing their positions, 42 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more funds holding
Funds holding: 157 → 185 (+28)
26% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $14.3M
Holders
185
Holding in Top 10
10
Calls
$10.6M
Puts
$14.3M
Top Buyers
| 1 | +$81.9M | |
| 2 | +$58.5M | |
| 3 | +$48.5M | |
| 4 |
TAL
TIG Advisors LLC
New York
|
+$34.3M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$31M |
Top Sellers
| 1 | -$69.5M | |
| 2 | -$60.3M | |
| 3 | -$59.1M | |
| 4 |
O
OrbiMed
New York
|
-$47M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$44.3M |